Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene - Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype

被引:55
作者
Weng, Y
DiRusso, CC
Reilly, AA
Black, PN
Ding, XX
机构
[1] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA
[2] SUNY Albany, Albany, NY 12201 USA
[3] Ordway Res Inst Inc, Albany, NY 12208 USA
关键词
D O I
10.1074/jbc.M504447200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NADPH-cytochrome P450 reductase (CPR) is an essential component for the function of many enzymes, including microsomal cytochrome P450 ( P450) monooxygenases and heme oxygenases. In liver-Cpr-null ( with liver-specific Cpr deletion) and Cpr-low ( with reduced CPR expression in all organs examined) mouse models, a reduced serum cholesterol level and an induction of hepatic P450s were observed, whereas hepatomegaly and fatty liver were only observed in the liver-Cpr- null model. Our goal was to identify hepatic gene expression changes related to these phenotypes. Cpr-lox mice ( with a floxed Cpr gene and normal CPR expression) were used as the control. Through microarray analysis, we identified many genes that were differentially expressed among the three groups of mice. We also recognized the 12 gene ontology terms that contained the most significantly changed gene expression in at least one of the two mouse models. We further uncovered potential mechanisms, such as an increased activation of constitutive androstane receptor and a decreased activation of peroxisomal proliferatoractivated receptor-alpha by precursors of cholesterol biosynthesis, that underlie common changes ( e. g. induction of multiple P450s and suppression of genes for fatty acid metabolism) in response to CPR loss in the two mouse models. Additionally, we observed model-specific gene expression changes, such as the induction of a fatty-acid translocase (Cd36 antigen) and the suppression of carnitine O-palmitoyltransferase 1 (Cpt1a) and acyl-CoA synthetase long chain family member 1 (Acsl1), that are potentially responsible for the severe hepatic lipidosis and an altered fatty acid profile observed in liver-Cpr-null mice.
引用
收藏
页码:31686 / 31698
页数:13
相关论文
共 76 条
[1]   Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor α, retinoid X receptor, and liver X receptor in mouse liver [J].
Anderson, SP ;
Dunn, C ;
Laughter, A ;
Yoon, L ;
Swanson, C ;
Stulnig, TM ;
Steffensen, KR ;
Chandraratna, RAS ;
Gustafsson, JÅ ;
Corton, JC .
MOLECULAR PHARMACOLOGY, 2004, 66 (06) :1440-1452
[2]   Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα) [J].
Aoyama, T ;
Peters, JM ;
Iritani, N ;
Nakajima, T ;
Furihata, K ;
Hashimoto, T ;
Gonzalez, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5678-5684
[3]   Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP) [J].
Bae, YJ ;
Kemper, JK ;
Kemper, B .
DNA AND CELL BIOLOGY, 2004, 23 (02) :81-91
[4]  
CASTILLOOLIVARE.A, 2001, NUCLEIC ACIDS RES, V29, P4035
[5]  
CASTILLOOLIVARE.A, 2004, J BIOL CHEM, V279, P16813
[6]   Bile acid regulation of gene expression: Roles of nuclear hormone receptors [J].
Chiang, JYL .
ENDOCRINE REVIEWS, 2002, 23 (04) :443-463
[7]  
Coon M J, 1978, Methods Enzymol, V52, P109
[8]   Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats [J].
Coort, SLM ;
Hasselbaink, DM ;
Koonen, DPY ;
Willems, J ;
Coumans, WA ;
Chabowski, A ;
van der Vusse, GJ ;
Bonen, A ;
Glatz, JFC ;
Luiken, JJFP .
DIABETES, 2004, 53 (07) :1655-1663
[9]   GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways [J].
Dahlquist, KD ;
Salomonis, N ;
Vranizan, K ;
Lawlor, SC ;
Conklin, BR .
NATURE GENETICS, 2002, 31 (01) :19-20
[10]   Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].
Desvergne, B ;
Wahli, W .
ENDOCRINE REVIEWS, 1999, 20 (05) :649-688